期刊
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY
卷 12, 期 6, 页码 648-657出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ACI.0b013e32835a11d6
关键词
adjuvants in vaccines; depot carrier; immune system; subcutaneous immunotherapy; sublingual immunotherapy
资金
- ALK-Abello, Denmark
- Allergopharma, Germany
- Stallergenes, France
- HAL, The Netherlands
- Artu Biologicals, The Netherlands
- Allergy-Therapeutics/Bencard, UK/Germany
- Hartington, Spain
- Lofarma, Italy
- Novartis/Leti, Germany/Spain
- Glaxo-Smith-Kline, UK/Germany
- Essex-Pharma, Germany
- Cytos, Switzerland
- Curalogic, Denmark
- Roxall, Germany
- Biomay, Austria
- HAL Allergy, Netherlands/Germany
- Merck-Sharp and Dohme
- Astra-Zeneca
- Glaxo-Smith-Klein
- Nutricia (Danone)
- UCB
- Pfizer
- Almirall
- Senosian
- Danone
- Hollister-Stier
- ALK Abello
- GSK
Purpose of review This article gives an overview about the current state of preclinical and clinical studies using different kinds of adjuvants and their effect on allergen-specific immunotherapy (SIT). Recent findings Recently, vectors such as liposomes and microspheres and adjuvants such as Toll-like-receptor agonists [e.g. nonmethylated cytosine-guanine dinucleotide (CpG) motifs derived from bacterial DNA or monophosphoryl lipid A (MPL A)] have been used in clinical phase II and III trials demonstrating encouraging clinical effects. Summary SIT has been optimized for more than 100 years with different approaches. Among these, adjuvants have been shown to amplify the effect of SIT by modulating the immune response to this therapy. In the first part, this article reviews the immunological mechanisms underlying the use of adjuvants targeting key cells of the innate immune system such as dendritic cells. In the second part, it overviews first clinical trials which have been reported so far in both subcutaneous and sublingual allergen-specific immunotherapy investigating the therapeutic potential of adjuvanted extracts. Most of these clinical trials revealed both clinical efficacy and immunological effects. However, more studies are warranted to further focus the specific role of adjuvants in the process of tolerance induction in allergic patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据